1. Reduction of direct health costs associated with pertussis vaccination with acellular vaccines in children aged 0–9 years with pertussis in Catalonia (Spain)
- Author
-
Mireia Jané, Gloria Carmona, Pedro Plans-Rubió, Pere Godoy, E. Navas, Pedro Brotons, Angela Domínguez, and C. Muñoz-Almagro
- Subjects
0301 basic medicine ,Vacunas ,medicine.medical_specialty ,030106 microbiology ,Severe disease ,Children -- Health and hygiene ,Vacunes ,03 medical and health sciences ,0302 clinical medicine ,Pertussis ,Internal medicine ,Chi-square test ,Medicine ,Tos ferina ,Pharmacology (medical) ,Pertussis vaccination ,030212 general & internal medicine ,Original Research Article ,Infants -- Salut i higiene ,Pharmacology ,Vaccines ,Multivariable linear regression ,business.industry ,Health Policy ,Odds ratio ,Tosferina ,Multiple linear regression analysis ,Acellular vaccines ,business ,Niños -- Salud e higiene - Abstract
Objectives: The aim of this study was to assess direct health costs in children with pertussis aged 0–9 years who were vaccinated, partially vaccinated, and unvaccinated during childhood, and to assess the association between pertussis costs and pertussis vaccination in Catalonia (Spain) in 2012–2013. Methods: Direct healthcare costs included pertussis treatment, pertussis detection, and preventive chemotherapy of contacts. Pertussis patients were considered vaccinated when they had received 4–5 doses, and unvaccinated or partially vaccinated when they had received 0–3 doses of vaccine. The Chi square test and the odds ratios were used to compare percentages and the t test was used to compare mean pertussis costs in different groups, considering a p
- Published
- 2019